ES2611155T3 - Subgrupos novedosos de pacientes para trombólisis - Google Patents

Subgrupos novedosos de pacientes para trombólisis Download PDF

Info

Publication number
ES2611155T3
ES2611155T3 ES08838897.0T ES08838897T ES2611155T3 ES 2611155 T3 ES2611155 T3 ES 2611155T3 ES 08838897 T ES08838897 T ES 08838897T ES 2611155 T3 ES2611155 T3 ES 2611155T3
Authority
ES
Spain
Prior art keywords
stroke
patient
patients
demoteplase
timi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08838897.0T
Other languages
English (en)
Spanish (es)
Inventor
Mariola Söhngen
Alice Ebel
Yasir Alaa Shafeek Al-Rawi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2611155(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP07020401A external-priority patent/EP2050462A1/en
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Application granted granted Critical
Publication of ES2611155T3 publication Critical patent/ES2611155T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES08838897.0T 2007-10-18 2008-10-20 Subgrupos novedosos de pacientes para trombólisis Active ES2611155T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP07020401 2007-10-18
EP07020401A EP2050462A1 (en) 2007-10-18 2007-10-18 Improved treatment of stroke patients
EP07022867 2007-11-26
EP07022867 2007-11-26
EP08017954 2008-10-15
EP08017954 2008-10-15
PCT/EP2008/008871 WO2009049914A2 (en) 2007-10-18 2008-10-20 Novel patient subgroups for thrombolysis

Publications (1)

Publication Number Publication Date
ES2611155T3 true ES2611155T3 (es) 2017-05-05

Family

ID=40567844

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08838897.0T Active ES2611155T3 (es) 2007-10-18 2008-10-20 Subgrupos novedosos de pacientes para trombólisis

Country Status (28)

Country Link
US (2) US20100272704A1 (cg-RX-API-DMAC7.html)
EP (1) EP2211898B1 (cg-RX-API-DMAC7.html)
JP (2) JP5509085B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100089077A (cg-RX-API-DMAC7.html)
CN (1) CN101903039B (cg-RX-API-DMAC7.html)
AR (1) AR068914A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008314048B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0817785A2 (cg-RX-API-DMAC7.html)
CA (1) CA2702378A1 (cg-RX-API-DMAC7.html)
CL (1) CL2009000752A1 (cg-RX-API-DMAC7.html)
CY (1) CY1118417T1 (cg-RX-API-DMAC7.html)
DK (1) DK2211898T3 (cg-RX-API-DMAC7.html)
EA (1) EA020776B1 (cg-RX-API-DMAC7.html)
ES (1) ES2611155T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20170001T1 (cg-RX-API-DMAC7.html)
HU (1) HUE032867T2 (cg-RX-API-DMAC7.html)
IL (1) IL205175A0 (cg-RX-API-DMAC7.html)
LT (1) LT2211898T (cg-RX-API-DMAC7.html)
MX (1) MX2010004157A (cg-RX-API-DMAC7.html)
MY (1) MY159200A (cg-RX-API-DMAC7.html)
NZ (1) NZ584640A (cg-RX-API-DMAC7.html)
PL (1) PL2211898T3 (cg-RX-API-DMAC7.html)
PT (1) PT2211898T (cg-RX-API-DMAC7.html)
RS (1) RS55590B1 (cg-RX-API-DMAC7.html)
SI (1) SI2211898T1 (cg-RX-API-DMAC7.html)
TW (1) TWI482628B (cg-RX-API-DMAC7.html)
WO (1) WO2009049914A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201002548B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US5244806A (en) * 1985-08-26 1993-09-14 Eli Lilly And Company DNA encoding novel tissue plasminogen activator derivatives having kringles 1 and 2 deleted, vectors and host cells
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
US5676947A (en) * 1989-02-07 1997-10-14 Boehringer Manneheim Gmbh Method for treating thromboembolic conditions using thrombolytically active proteins
US6008019A (en) * 1989-02-13 1999-12-28 Schering Aktiengesellschaft Plasminogen activator from saliva of the vampire bat
US5891664A (en) * 1989-04-07 1999-04-06 Cancerforskningsfondet Af 1989 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
CA2107476C (en) * 1991-04-16 2007-12-18 Martin Ulrich Pharmaceutical packaging unit containing plasminogen activators for multiple bolus administration
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
DE59307091D1 (de) * 1992-12-04 1997-09-11 Schering Ag Thrombininhibitor aus speichel von protostomiern
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
US5827832A (en) * 1995-03-06 1998-10-27 Interneuron Pharmaceuticals, Inc. Method of protecting brain tissue from cerebral infarction subsequent to ischemia
US5786187A (en) * 1995-09-21 1998-07-28 The Research Foundation Of State University Of New York Method for reducing neuronal degeneration associated with seizure
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US20020081294A1 (en) * 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
US6354999B1 (en) * 2000-01-14 2002-03-12 Florence Medical Ltd. System and method for detecting, localizing, and characterizing occlusions and aneurysms in a vessel
GB0025473D0 (en) * 2000-10-17 2000-11-29 Pfizer Ltd Pharmaceutical combinations
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
US20080057050A1 (en) * 2003-05-02 2008-03-06 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
US20060135425A1 (en) * 2003-05-02 2006-06-22 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
KR20060015721A (ko) * 2003-05-05 2006-02-20 파이온 도이치란트 게엠베하 신경보호제로서의 글루타메이트 수용체 길항제
US20050085478A1 (en) * 2003-08-22 2005-04-21 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage
CN101248083A (zh) * 2005-08-25 2008-08-20 比奥根艾迪克Ma公司 Nogo受体多肽和多肽片段及其用途

Also Published As

Publication number Publication date
EP2211898B1 (en) 2016-12-07
IL205175A0 (en) 2010-11-30
JP2014065739A (ja) 2014-04-17
EP2211898A2 (en) 2010-08-04
CN101903039A (zh) 2010-12-01
AU2008314048A1 (en) 2009-04-23
CL2009000752A1 (es) 2009-12-04
HRP20170001T1 (hr) 2017-02-24
CN101903039B (zh) 2014-04-02
MY159200A (en) 2016-12-30
US20140314736A1 (en) 2014-10-23
HUE032867T2 (en) 2017-11-28
PL2211898T3 (pl) 2017-03-31
MX2010004157A (es) 2010-04-30
PT2211898T (pt) 2017-01-31
SI2211898T1 (sl) 2017-02-28
JP5509085B2 (ja) 2014-06-04
EA201070485A1 (ru) 2010-10-29
KR20100089077A (ko) 2010-08-11
BRPI0817785A2 (pt) 2015-03-24
ZA201002548B (en) 2011-06-29
DK2211898T3 (en) 2017-01-30
WO2009049914A2 (en) 2009-04-23
EA020776B1 (ru) 2015-01-30
AR068914A1 (es) 2009-12-16
JP2011500617A (ja) 2011-01-06
CA2702378A1 (en) 2009-04-23
TWI482628B (zh) 2015-05-01
TW200927164A (en) 2009-07-01
AU2008314048B2 (en) 2013-07-25
HK1151233A1 (en) 2012-01-27
US20100272704A1 (en) 2010-10-28
NZ584640A (en) 2012-10-26
WO2009049914A3 (en) 2009-08-06
CY1118417T1 (el) 2017-06-28
LT2211898T (lt) 2017-01-25
RS55590B1 (sr) 2017-06-30

Similar Documents

Publication Publication Date Title
Dorado et al. Reperfusion therapies for acute ischemic stroke: an update
Sonni et al. New avenues for treatment of intracranial hemorrhage
Fulgham et al. Management of acute ischemic stroke
Wu et al. Assessing the clinical efficacy of recombinant tissue plasminogen activator on acute cerebral infarction
Logallo et al. Novel thrombolytics for acute ischemic stroke: challenges and opportunities
EP2050462A1 (en) Improved treatment of stroke patients
ES2772802T3 (es) Composiciones y procedimientos para tratar la hemorragia intracerebral
DK2211898T3 (en) New patient subgroup for thrombolysis
Xianxian et al. The efficiency analysis of thrombolytic rt-PA combined with intravascular interventional therapy in patients with acute basilar artery occlusion
WO2008124974A1 (fr) Utilisation de la kallidinogénase de l'urine humaine dans la fabrication d'un médicament pour le traitement et/ou la prévention de l'hypertension compliquée par un infarctus cérébral
JP2017533961A (ja) 安全かつ効果的な血栓溶解(Thrombolysis)のための方法および組成物
JP2011500617A5 (cg-RX-API-DMAC7.html)
Ngoc et al. Thrombolysis and thrombectomy as an effective treatment for ischemic cerebral circulation disorders
CN105148261A (zh) 尿激酶原及尿激酶原变体在急性心肌梗塞易化经皮冠状动脉介入中的应用
Venketasubramanian et al. Brain attack: needing resuscitation
Leker et al. Novel therapies for acute ischemic stroke
JP2016513131A (ja) 羊水塞栓の治療剤
HK1151233B (en) Novel patient subgroups for thrombolysis
ALSOMALI et al. RECENT DEVELOPMENTS AND INNOVATIONS IN EMERGENCY DEPARTMENT FOR THE MANAGEMENT AND TREATMENT OF ACUTE ISCHEMIC STROKE
Wirkowski et al. Tissue plasminogen activator for acute stroke in everyday clinical practice
Arauz et al. Cerebrovascular disease
Haley Thrombolysis in the treatment of acute ischemic stroke
Schellinger Stroke management in the early phase
CN114984197A (zh) 替奈普酶在制备用于治疗急性缺血性卒中的药物组合物中的应用
Csiba et al. Fibrin-degrading drugs in acute stroke